A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

NCT01558271 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

492

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: LY2189265
DRUG: Placebo
DRUG: Liraglutide

Sponsor

Eli Lilly and Company